ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 120 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $215,362 | -15.2% | 65,659 | -2.2% | 0.00% | – |
| Q3 2022 | $254,000 | -46.3% | 67,118 | +10.5% | 0.00% | -100.0% |
| Q2 2022 | $473,000 | -16.1% | 60,728 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $564,000 | +130.2% | 60,728 | +308.8% | 0.00% | 0.0% |
| Q4 2019 | $245,000 | +16.7% | 14,857 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $210,000 | -29.8% | 14,857 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $299,000 | -49.6% | 14,857 | -0.3% | 0.00% | -50.0% |
| Q1 2019 | $593,000 | +14.9% | 14,907 | +0.3% | 0.00% | 0.0% |
| Q4 2018 | $516,000 | -16.9% | 14,857 | -1.1% | 0.00% | 0.0% |
| Q3 2018 | $621,000 | +21.1% | 15,018 | +7.5% | 0.00% | 0.0% |
| Q2 2018 | $513,000 | -3.4% | 13,968 | +2.7% | 0.00% | 0.0% |
| Q1 2018 | $531,000 | +282.0% | 13,607 | +36.7% | 0.00% | +100.0% |
| Q2 2017 | $139,000 | -32.2% | 9,957 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $205,000 | +45.4% | 9,957 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $141,000 | -33.8% | 9,957 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $213,000 | – | 9,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,610,000 | 11.42% |
| Redmile Group, LLC | 6,048,123 | $9,737,478 | 0.37% |
| Baupost Group | 9,773,616 | $15,736 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 170,000 | $273,700 | 0.27% |
| MAVERICK CAPITAL LTD | 6,290,713 | $10,128,048 | 0.22% |
| 683 Capital Management, LLC | 1,000,000 | $1,610,000 | 0.12% |
| WASATCH ADVISORS LP | 8,283,981 | $13,337,209 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $845,250 | 0.08% |
| STALEY CAPITAL ADVISERS INC | 750,000 | $1,207,500 | 0.06% |
| XTX Topco Ltd | 136,841 | $220,314 | 0.04% |